Tariquidar

Tariquidar

Uses

Investigated for use/treatment in ovarian cancer, lung cancer, and breast cancer.

How Tariquidar works

Tariquidar is an anthranilic acid derivative third generation P-glycoprotein (P-gp) inhibitors. P-gp is a transport protein found in normal cells that has many trasport and modulatory functions, from affecting the distribution and bioavailability of drugs to mediating the migration of dendritic cells. P-gp is responsible for multidrug resistance through transport of anti-cancer drugs out of their target cells. It is proposed that tariquidar's and its derivatives may bind to the H-binding site of P-gp through multiple mechanisms of binding.

Tariquidar

Trade Name	Tariquidar
Generic	Tariquidar
Tariquidar Other Names	Tariquidar
Type
Formula	C38H38N4O6
Weight	Average: 646.744 Monoisotopic: 646.27913496
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	August 5, 2021 at 12:40 pm

Structure

Table Of contents

• Tariquidar
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Innovators Monograph

You find simplified version here Tariquidar